Dergiler / Turkish journal of nephrology (Online) / 2019 / Cilt: 28 - Sayı: 2

Development and Psychometric Testing of the Turkish Immunosuppressive Medication Adherence Scale

Sayfa
120–126
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

The scale is appropriate for use in clinical practice settings and research to evaluate immunosuppressivemedication adherence of solid organ transplant patients.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: The monitoring of immunosuppressive medication adherence is an important issue for solid organ transplantpatients.
📊
Temel Bulgular & Veri:The aim of this methodological study was to develop and psychometrically test Immunosuppressive Medication Adherence Scale.Materials and Methods: The Immunosuppressive Medication Adherence Scale was developed, and its validity and reliability were examined using data from 200 solid organ transplant patients.
💡
Sonuç & Katkı:The scale is appropriate for use in clinical practice settings and research to evaluate immunosuppressivemedication adherence of solid organ transplant patients.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Objective: The monitoring of immunosuppressive medication adherence is an important issue for solid organ transplantpatients. In Turkey, there has been no valid and reliable measurement tool specific to transplantation for evaluation ofmedication adherence. The aim of this methodological study was to develop and psychometrically test Immunosuppressive Medication Adherence Scale.Materials and Methods: The Immunosuppressive Medication Adherence Scale was developed, and its validity and reliability were examined using data from 200 solid organ transplant patients. An expert panel evaluated the content validity,and factor analysis was used to evaluate the construct validity. Internal consistency analysis was performed to evaluate thereliability of the scale, and item–total correlations were evaluated.Results: As a result of exploratory factor analysis, all 11 items were found to be collected in a single dimension, and factorloadings varied between 0.32 and 0.87. All scale items had a good positive significant correlation with the total scale score.Content validity was evidenced by obtaining the views of 13 experts (0.80 content validity index). Cronbach’s α was 0.61.Conclusion: The Immunosuppressive Medication Adherence Scale has acceptable internal consistency, good content, andconstruct validity. The scale is appropriate for use in clinical practice settings and research to evaluate immunosuppressivemedication adherence of solid organ transplant patients.

🔖

Bu Makaleye Atıf Yap

KÖKEN, Z. Ö., TALAS, M. S., GÖKMEN, D. (2019). Development and Psychometric Testing of the Turkish Immunosuppressive Medication Adherence Scale. Turkish journal of nephrology (Online), Cilt: 28 - Sayı: 2, 120–126. https://ajindex.com/articles/374915

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (14)

  1. Dew MA, Di Martini AF, De Vito Dabbs A, Myaskovsky L, Steel J, Unruh M, et al. Rates and risk factors for nonadherence to the medical regimen after adult solid organ transplantation. Transplantation 2007
  2. [CrossRef] 2. Germani G, Lazzaro S, Gnoato F, Senzolo M, Borella V, Rupolo G, et al. Nonadherent behaviors after solid organ transplantation. Transplant Proc 2011
  3. [CrossRef] 3. Kung M, Koschwanez HE, Painter L, Honeyman V, Broadbent E. Immunosuppressant nonadherence in heart, liver, and lung transplant patients: Associations with medication beliefs and illness perceptions. Transplantation 2012
  4. [CrossRef] 4. De Bleser L, Matteson M, Dobbels F, Russell C, De Geest S. Interventions to improve medication-adherence after transplantation: A systematic review. Transpl Int 2009
  5. [CrossRef] 5. World Health Organization. Adherence to long-term therapies (Internet). Geneva: World Health Organization
  6. Available from: http:// www.who.int/chp/knowledge/publications/adherence_report/en/ 6. Brown MT, Bussell JK. Medication adherence: WHO cares? Mayo Clin Proc 2011
  7. [CrossRef] 7. Fine R, Becker Y, De Geest S, Eisend H, Ettengere R, Evanset R, et al. Nonadherence consensus conference summary report. Am J Transplant 2009
  8. [CrossRef] 8. Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X. Interventions for enhancing medication adherence. Cochrane Database Syst Rev 2008
  9. CD000011. [CrossRef] 9. Morrissey PE, Flynn ML, Lin S. Medication noncompliance and its implications in transplant recipients. Drugs 2007
  10. [CrossRef] 10. Balkrishnan R. The importance of medication adherence in improving chronic-disease related outcomes: What we know and what we need to further know. Med Care 2005
  11. [CrossRef] 11. De Bleser L, Dobbels F, Berben L, Vanhaecke J, Verleden G, Nevens F, et al. The spectrum of nonadherence with medication in heart, liver, and lung transplant patients assessed in various ways. Transpl Int 2011
  12. [CrossRef] 12. Dobbels F, Berben L, De Geest S, Drent G, Lennerling A, Whittaker C, Kugler C. The psychometric properties and practicability of self-report instruments to identify medication nonadherence in adult transplant patients: A systematic review. Transplantation 2010
  13. [CrossRef] 13. Ho PM, Bryson CL, Rumsfeld JS. Medication adherence: Its importance in cardiovascular outcomes. Circulation 2009
  14. [CrossRef] 14. Laufs U, Rettig-Ewen